i I think that is a lot of invisible dots connected to reach a pessimistic conclusion.
Even if it were possible the management team of Neuren thought of doing this (can't believe they would contemplate it anyway) what material difference does it make in the end? Nada.
i'm sticking to the simple notion that 2591 is a very effective drug that I hope can translate into a positive impact on PH sufferers.
Ann: 2023 Annual Report to shareholders, page-162
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.79 |
Change
-0.280(1.99%) |
Mkt cap ! $1.762B | |||
| Open | High | Low | Value | Volume |
| $13.73 | $13.88 | $13.40 | $9.796M | 714.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1588 | $13.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.84 | 1625 | 2 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |